Menu
 
Research menu
Jump to menu

Publications:  Dr Ranjit Manchanda

Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.(2019). A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer. JAMA Oncology
10.1001/jamaoncol.2019.3323
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60755
Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al. (2019). ATTITUDE TOWARDS AND FACTORS AFFECTING UPTAKE OF POPULATION BASED BRCA TESTING IN ASHKENAZI JEWS: A COHORT STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A42-A43.
10.1136/ijgc-2019-IGCS.81
Manchanda R, Sun L, Patel S, Wilschut J, Lopes Carolina de Freitas A, Brentnall A, Duffy S, Cui B et al. (2019). GLOBAL ECONOMIC EVALUATION OF POPULATION-BASED BRCA1/BRCA2 MUTATION TESTING. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A6-A7.
10.1136/ijgc-2019-IGCS.10
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.(2019). SHOULD WE OFFER MULTI-GENE TESTING TO ALL PATIENTS WITH BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 29, A36-A37.
10.1136/ijgc-2019-IGCS.66
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59878
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 82-82.
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 84-84.
Tan A, Rivas C, Yorke S, Khan K, Rogozinska E, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 85-85.
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 86-87.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.(2019). Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. Gynecologic Oncology
10.1016/j.ygyno.2019.04.679
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58607
Crosbie E, MANCHANDA R, Manchester International Consensus Group(2019). The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genetics in Medicine
10.1038/s41436-019-0489-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56622
GABA F, Piek J, Menon U, MANCHANDA R(2019). Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary. BJOG: An International Journal of Obstetrics and Gynaecology
10.1111/1471-0528.15651
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55319
MANCHANDA R, GABA F(2019). A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm. BJOG: An International Journal of Obstetrics and Gynaecology
10.1111/1471-0528.15657
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55616
Koutoukidis D, Beeken R, MANCHANDA R, Burnell M, Ziauddeen N, Michalopoulou M, Knobf MT, Lanceley A(2019). Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial. International Journal of Gynecological Cancer vol. 29, (3)
10.1136/ijgc-2018-000039
https://qmro.qmul.ac.uk/xmlui/handle/123456789/49823
MANCHANDA R, Matthew B, GABA F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al.(2019). Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology
10.1111/1471-0528.15654
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55771
Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I et al.(2019). Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results. Histopathology
10.1111/his.13925
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60981
Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al.(2019). Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. BJOG: An International Journal of Obstetrics and Gynaecology
10.1111/1471-0528.15905
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60978
Osman M, Chandrasekaran D, Musa E, Afnan-Holmes H, Brockbank E, Lawrence A, Manchanda R (2018). Evaluation of the diagnostic hysteroscopy service in gynaecology oncology. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. Conference: National Trainees Conference 2018 vol. 125, 24-24.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56070
MANCHANDA R, GABA F(2018). Population Based Testing for Primary Prevention: A Systematic Review. Cancers
10.3390/cancers10110424
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51824
Puntambekar S, MANCHANDA R(2018). Surgical pelvic anatomy in gynecologic oncology. International Journal of Gynecology and Obstetrics vol. 143, 86-92.
10.1002/ijgo.12616
https://qmro.qmul.ac.uk/xmlui/handle/123456789/47924
MANCHANDA R, Legood R(2018). Population based germline testing for primary cancer prevention. Oncotarget vol. 9, (69) 33062-33063.
10.18632/oncotarget.25995
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45084
Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Gan C, Taylor R et al.(2018). Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. Journal of Medical Genetics vol. 55, (8) 538-545.
10.1136/jmedgenet-2017-105195
https://qmro.qmul.ac.uk/xmlui/handle/123456789/38363
Yang X, Leslie G, Gentry-Maharaj A, Ryan A, Intermaggio M, Lee A, Kalsi JK, Tyrer J et al.(2018). Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. Journal of Medical Genetics vol. 55, (8) 546-554.
10.1136/jmedgenet-2018-105313
https://qmro.qmul.ac.uk/xmlui/handle/123456789/37923
Vazquez MA, Marino IP, BLYUSS O, Ryan A, GENTRY-MAHARAJ A, Kalsi J, MANCHANDA R, Jacobs I et al.(2018). A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer. Biomedical Signal Processing and Control
10.1016/j.bspc.2018.07.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42483
Cohen P, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.(2018). Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data.
BLYUSS O, Burnell M, Ryan A, GENTRY-MAHARAJ A, Marino I, Kalsi J, MANCHANDA R, Timms JF et al.(2018). Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population. Clinical Cancer Research
10.1158/1078-0432.CCR-18-0208
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42484
Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ et al.(2018). Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. Gynecologic Oncology Reports
10.1016/j.gore.2018.05.005
https://qmro.qmul.ac.uk/xmlui/handle/123456789/41283
Chandrasekaran D, Manchanda R(2018). Germline & somatic genetic testing in ovarian cancer patients. BJOG
10.1111/1471-0528.15225
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36592
Patel S, Legood R, Evans DG, Turnbull C, Antoniou AC, Menon U, Jacobs I, Manchanda R(2018). Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women. American Journal of Obstetrics and Gynecology vol. 218, (4) 431.e1-431.e12.
10.1016/j.ajog.2017.12.221
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31164
Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ et al.(2018). Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. Journal of the National Cancer Institute vol. 110, (7) 714-725.
10.1093/jnci/djx265
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35943
MANCHANDA R, Menon U(2018). Setting the threshold for surgical prevention in women at increased risk of ovarian cancer. International Journal of Gynecological Cancer
10.1097/IGC.0000000000001147
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31163
Meisel SF, Freeman M, Waller J, Fraser L, Gessler S, Jacobs I, Kalsi J, Rahman B et al.(2017). Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study. BMC Public Health vol. 17, Article 882,
10.1186/s12889-017-4889-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/29163
Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ et al.(2017). Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry. American Journal of Obstetrics and Gynecology vol. 217, (5) 578.e1-578.e12.
10.1016/j.ajog.2017.06.038
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24965
Koutoukidis DA, Beeken RJ, Manchanda R, Michalopoulou M, Burnell M, Knobf MT, Lanceley A(2017). Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial. BMJ Open vol. 7, (10)
10.1136/bmjopen-2017-018015
https://qmro.qmul.ac.uk/xmlui/handle/123456789/30603
Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR et al.(2017). Persistence of fimbrial tissue on the ovarian surface after salpingectomy. American Journal of Obstetrics and Gynecology vol. 217, (4) 425.e1-425.e16.
10.1016/j.ajog.2017.06.004
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24890
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.(2017). Evidence of Stage Shift in Women Diagnosed with Ovarian Cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. Obstetrical and Gynecological Survey vol. 72, (6) 338-340.
10.1097/01.ogx.0000520207.28837.3a
https://qmro.qmul.ac.uk/xmlui/handle/123456789/48284
MANCHANDA R, Legood R, Antoniou AC, Pearce L, Menon U(2017). Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer. BJOG: An International Journal of Obstetrics and Gynaecology
10.1111/1471-0528.14763
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24546
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.(2017). Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. J Clin Oncol vol. 35, (13) 1411-1420.
10.1200/JCO.2016.69.9330
https://qmro.qmul.ac.uk/xmlui/handle/123456789/21300
Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L(2017). Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges. Gynecologic Oncology Reports vol. 20, 9-14.
10.1016/j.gore.2017.01.003
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19546
Manchanda R(2017). Opportunistic salpingectomy for prevention of ovarian cancer. BJOG: An International Journal of Obstetrics and Gynaecology vol. 124, (6) 890-890.
10.1111/1471-0528.14655
https://qmro.qmul.ac.uk/xmlui/handle/123456789/23063
Gan C, Bossart M, Piek J, Halaska M, Haidopoulos D, Zapardiel I, Grabowski JP, Kesic V et al.(2017). Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees. International Journal of Gynecological Cancer vol. 27, (2) 375-381.
10.1097/IGC.0000000000000879
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19547
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A(2017). Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1. Trials vol. 18, (1) 28-28.
10.1186/s13063-017-1776-z
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19539
Gaba FM, Manchanda R, Gaba FM, Manchanda R(2017). Genetic testing for gynaecological cancer. Obstetrics, Gynaecology and Reproductive Medicine vol. 27, (1) 29-31.
10.1016/j.ogrm.2016.11.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18971
Burnell M, Iyer R, Gentry-Maharaj A, Nordin A, Liston R, Manchanda R, Das N, Gornall R et al.(2016). Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study. BJOG : an international journal of obstetrics and gynaecology vol. 123, (13) 2171-2180.
10.1111/1471-0528.13994
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12657
Pennington M, Gentry-Maharaj A, Karpinskyj C, Miners A, Taylor J, Manchanda R, Iyer R, Griffin M et al.(2016). Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). PLoS One vol. 11, (11) Article 0165539, e0165539-e0165539.
10.1371/journal.pone.0165539
https://qmro.qmul.ac.uk/xmlui/handle/123456789/17827
La Russa M, Biliatis I, Brockbank E, Faruki A, Lawrence A, Manchanda R, Singh N, Jeyarajah A (2016). CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting (Lisbon, Portugal) from: 29/10/2016 to: 31/10/2016, vol. 26, 1013-1013.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18943
Manchanda R, Gordeev V, Antoniou A, Smith S, Lee A, Hopper J, Macinnis R, Paul P et al. (2016). Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016) vol. 26, 59-60.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18946
Kumar S, Long J, Rudge G, Manchanda R, Fotopoulou C, Wood N, Duncan T, Balega J et al. (2016). SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal (Lisbon, Portugal) from: 29/10/2016 to: 31/10/2016, vol. 26, 832-833.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24955
Manchanda R, Legood R, Antoniou AC, Gordeev VS, Menon U(2016). Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingooophorectomy' for ovarian cancer prevention: A cost-effectiveness analysis. Journal of Medical Genetics vol. 53, (9) 591-599.
10.1136/jmedgenet-2016-103800
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13144
Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L et al.(2016). Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations. Journal of Medical Genetics vol. 53, (7) 472-480.
10.1136/jmedgenet-2015-103740
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12152
Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens AL, Cibula D, Bookman MA et al.(2016). Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. International Journal of Gynecological Cancer vol. 26, (6) 1186-1188.
10.1097/IGC.0000000000000735
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15553
Manchanda R, Cibula D(2016). Ovarian Cancer Screening There May Be Light at the End of the Tunnel?. Int J Gynecol Cancer vol. 26, (4) 608-609.
10.1097/IGC.0000000000000706
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12881
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A(2016). Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. Trials vol. 17, (1)
10.1186/s13063-016-1260-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12157
MANCHANDA R, Menon U(2016). Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial FOR: There is lack of clarity on a number of key issues. BJOG: an International Journal of Obstetrics and Gynaecology vol. 123, (3) 463-463.
10.1111/1471-0528.13741
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11153
Manchanda R, Jacobs I(2016). Genetic screening for gynecological cancer: Where are we heading?. Future Oncology vol. 12, (2) 207-220.
10.2217/fon.15.278
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10784
Manchanda R, Chandrasekaran D, Saridogan E, Burnell M, Crawford R, Brockbank E, Kalsi J, Jurkovic D et al.(2016). Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated into Routine Care or Offered in the Context of a Clinical Trial?. International Journal of Gynecological Cancer vol. 26, (1) 31-33.
10.1097/IGC.0000000000000567
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10777
Blyuss KB, MANCHANDA R, Kurths J, Alsaedi A, Zaikin A(2016). Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks. Computational and Mathematical Methods in Medicine vol. 2016, Article 7904693,
10.1155/2016/7904693
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11154
Dilley J, Manchanda R, Johnson M, Rosenthal AN, Gessler S, Menon U(2016). Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients. International Journal of Gynecology & Obstetrics vol. 133, (2) 239-240.
10.1016/j.ijgo.2015.09.013
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12243
Manchanda R, Legood R, Pearce L, Menon U(2015). Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. Gynecologic Oncology vol. 139, (3) 487-494.
10.1016/j.ygyno.2015.10.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10775
Manchanda R, Loggenberg K, Burnell M, Wardle J, Sanderson S, Gessler S, Side L, Balogun N et al. (2015). A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 25, 48-49.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/39589
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.(2015). Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Familial Cancer vol. 14, (4) 521-530.
10.1007/s10689-015-9823-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10800
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.(2015). Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Familial Cancer
10.1007/s10689-015-9823-y
Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF et al.(2015). A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. Journal of Medical Genetics vol. 52, (7) 465-475.
10.1136/jmedgenet-2015-103077
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12239
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S et al.(2015). Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. Journal of the National Cancer Institute vol. 107, (1)
10.1093/jnci/dju380
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11002
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al.(2015). Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial. Journal of the National Cancer Institute vol. 107, (1)
10.1093/jnci/dju379
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12434
Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R et al.(2015). Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC - UK gynaecological oncology surgical outcomes and complications). British Journal of Cancer vol. 112, (3) 475-484.
10.1038/bjc.2014.630
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12471
Piek J, Bossart M, Boor K, Halaska M, Haidopoulos D, Zapardiel I, Grabowski J, Kesic V et al.(2015). The work place educational climate in gynecological oncology fellowships across Europe the impact of accreditation. International Journal of Gynecological Cancer vol. 25, (1) 180-190.
10.1097/IGC.0000000000000323
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14953
Manchanda R, Legood R, Burnell M, McGuire A, Loggenberg K, Wardle J, Sanderson S, Gessler S et al.(2014). POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 24, (9) 470-471.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12313
Philpott S, Rizzuto I, Fraser L, Manchanda R, Hadwin R, Burnell M, Mackay S, Skates S et al.(2013). DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23, (8)
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45783
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al.(2013). RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23, (8)
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56557
Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, Gultekin M, Vranes B et al.(2013). The need for more workshops in laparoscopic surgery and surgical anatomy for european gynaecological oncology trainees: A survey by the european network of young gynaecological oncologists. International Journal of Gynecological Cancer vol. 23, (6) 1126-1131.
10.1097/IGC.0b013e31829703b0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12334
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). JOURNAL OF CLINICAL ONCOLOGY. vol. 31,
Manchanda R, Godfrey M, Wong-Taylor LA, Halaska MJ, Burnell M, Grabowski JP, Gultekin M, Haidopoulos D et al.(2013). The need for accredited training in gynaecological oncology: A report from the european network of young gynaecological oncologists (ENYGO). Annals of Oncology vol. 24, (4) 944-952.
10.1093/annonc/mds588
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12226
Kalsi JK, Manchanda R, Menon U(2013). Screening for gynecological cancers. Expert Review of Obstetrics and Gynecology vol. 8, (2) 143-160.
10.1586/eog.13.5
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13602
Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH et al.(2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. Journal of Clinical Oncology vol. 31, (1) 49-57.
10.1200/JCO.2011.39.7638
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13391
Manchanda R, Drapkin R, Menon U(2013). There is a need for routine peritoneal cytology at RRSO. Gynecologic Oncology vol. 128, (1) 149-150.
10.1016/j.ygyno.2012.09.031
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12304
Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Side L et al.(2012). Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). Archives of Gynecology and Obstetrics vol. 286, (6) 1555-1562.
10.1007/s00404-012-2492-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12296
Fourkala EO, Gentry-Maharaj A, Burnell M, Ryan A, Manchanda R, Dawnay A, Jacobs I, Widschwendter M et al.(2012). Histological confirmation of breast cancer registration and self-reporting in England and Wales: A cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. British Journal of Cancer vol. 106, (12) 1910-1916.
10.1038/bjc.2012.155
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10809
Manchanda R, Silvanto A, Abdelraheim A, Burnell M, Johnson M, Saridogan E, Rosenthal AN, Brunell C et al.(2012). Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy. International Journal of Gynecological Cancer vol. 22, (5) 881-888.
10.1097/IGC.0b013e31824b4093
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12233
Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A(2012). International conference on ovarian cancer screening 29th-30th November 2011, Royal College of Physicians, London. International Journal of Gynecological Cancer vol. 22, (SUPPL. 1)
10.1097/IGC.0b013e3182557e41
Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E et al.(2012). Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis. BJOG: An International Journal of Obstetrics and Gynaecology vol. 119, (5) 527-536.
10.1111/j.1471-0528.2011.03257.x
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12664
Gentry-Maharaj A, Kalsi J, Burnell M, Manchanda R, Menon U(2012). Screening of symptomatic women for ovarian cancer. The Lancet Oncology vol. 13, (4)
10.1016/S1470-2045(12)70120-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13651
Vaes E, Manchanda R, Autier P, Nir R, Nir D, Bleiberg H, Robert A, Menon U(2012). Differential diagnosis of adnexal masses: Sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool. Ultrasound in Obstetrics and Gynecology vol. 39, (1) 91-98.
10.1002/uog.9079
Brantnerova R, Manchanda R, Colombo N(2012). The European society of gynaecological oncology: update on objectives and educational and research activities. Am Soc Clin Oncol Educ Book335-338.
10.14694/EdBook_AM.2012.32.335
Manchanda R, Drapkin R, Jacobs I, Menon U(2012). The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecologic Oncology vol. 124, (2) 185-191.
10.1016/j.ygyno.2011.10.017
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12268
Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JMJ, Manchanda R et al.(2011). Gynecologic oncology training systems in Europe: A report from the European network of young gynaecological oncologists. International Journal of Gynecological Cancer vol. 21, (8) 1500-1506.
10.1097/IGC.0b013e3182202d17
Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L et al.(2011). Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG: An International Journal of Obstetrics and Gynaecology vol. 118, (7) 814-824.
10.1111/j.1471-0528.2011.02920.x
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14031
Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Autier P, Menon U, Robert A(2011). Mathematical models to discriminate between benign and malignant adnexal masses: Potential diagnostic improvement using ovarian histoscanning. International Journal of Gynecological Cancer vol. 21, (1) 35-43.
10.1097/IGC.0b013e3182000528
Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW et al.(2011). Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort. The Lancet Oncology vol. 12, (1) 38-48.
10.1016/S1470-2045(10)70268-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15120
Pichert G, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al.(2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Familial Cancer vol. 9, (3) 313-319.
10.1007/s10689-010-9333-x
Manchanda R, Rosenthal A, Burnell M, Fraser L, Mackay J, Skates S(2009). Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers. Journal of Medical Genetics vol. 46, (6) 423-424.
10.1136/jmg.2009.067462
Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I(2009). Hereditary non-polyposis colorectal cancer or Lynch syndrome: The gynaecological perspective. Current Opinion in Obstetrics and Gynecology vol. 21, (1) 31-38.
10.1097/GCO.0b013e32831c844d
Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J, Welton K, Shafi M(2009). Is close follow up feasible for high-risk cervical premalignant lesion in developing countries? Author's reply. BJOG: An International Journal of Obstetrics and Gynaecology vol. 116, (1) 125-126.
10.1111/j.1471-0528.2008.02019.x
Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J, Welton K, Shafi M(2008). Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG: An International Journal of Obstetrics and Gynaecology vol. 115, (10) 1238-1242.
10.1111/j.1471-0528.2008.01853.x
Manchanda R, Palep-Singh M, Prentice A(2008). Can uterine artery embolisation affect endometrial perfusion and function. Journal of Obstetrics and Gynaecology vol. 28, (2) 246-248.
10.1080/01443610801967000
Manchanda R, Kriplani A(2005). Giant malignant ovarian tumor: A case report. International Journal of Gynecological Cancer vol. 15, (6) 1135-1137.
10.1111/j.1525-1438.2005.00196.x
Manchanda R, Sriemevan A(2005). Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta. Journal of Obstetrics and Gynaecology vol. 25, (2) 201-202.
10.1080/01443610500052013
Manchanda R, Refaie A(2005). Acute pneumoperitoneum following coitus. CJEM vol. 7, (1) 51-53.
10.1017/s148180350001294x
Manchanda R, Varma R, Anya I, Ting JYS(2004). Representation of authors and editors from poor countries [1] (multiple letters). British Medical Journal vol. 329, (7457) 110-111.
Manchanda R, Varma R(2004). Representation of authors and editors from poor countries: observed publication bias may reflect who is funding research. BMJ (Clinical research ed.) vol. 329, (7457)
10.1136/bmj.329.7457.110
Kriplani A, Agarwal N, Parul, Sharma MC, Manchanda R(2003). Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis. Journal of Obstetrics and Gynaecology Research vol. 29, (2) 63-66.
10.1046/j.1341-8076.2003.00028.x
Kriplani A, Manchanda R, Nath J, Takkar D(2002). A randomized trial of danazol pretreatment prior to endometrial resection. European Journal of Obstetrics and Gynecology and Reproductive Biology vol. 103, (1) 68-71.
10.1016/S0301-2115(02)00012-X
Kriplani A, Manchanda R, Monga D, Takkar D(2001). Depot medroxy progesterone acetate: A poor preparatory agent for endometrial resection. Gynecologic and Obstetric Investigation vol. 52, (3) 180-183.
10.1159/000052969
Kriplani A, Agarwal N, Roy KK, Manchanda R, Singh MK(2001). Laparoscopic management of Sertoli-Leydig cell tumors of the ovary: A report of two cases. Journal of Reproductive Medicine for the Obstetrician and Gynecologist vol. 46, (5) 493-496.
Kriplani A, Manchanda R, Agarwal N, Nayar B(2001). Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. Journal of the American Association of Gynecologic Laparoscopists vol. 8, (4) 511-518.
10.1016/S1074-3804(05)60613-5
Return to top